Extracellular RNA (exRNA)

Why in News?

• A 2026 study (journal Clean Water) shows exRNA persists in disinfected drinking water, enabling identification of bacterial survival strategies post-disinfection.
• Opens scope for next-generation disinfectants and advances in non-invasive diagnostics (liquid biopsy).

What is  Extracellular RNA (exRNA)?

exRNA  refers to RNA molecules present outside cells, found in fluids like blood, saliva, urine, cerebrospinal fluid, and even treated water.

• Earlier belief: RNA degrades rapidly outside cells; new evidence shows cells actively export RNA in protective vesicles, enabling stability and signalling.
• exRNA acts as a long-distance communication tool, transferring genetic instructions that regulate immune response, tissue repair, and development.
• Study shows exRNA remains detectable even after bacterial death, acting as a “molecular snapshot” of pre-death activity.
• Unlike DNA (which shows identity), exRNA reveals functional state—what genes were active under stress conditions.
• Enables mapping bacterial stress responses (heat-shock proteins, efflux pumps) under disinfectant exposure.
• Helps design synergistic disinfection strategies combining multiple methods (e.g., chlorine + UV) to block survival pathways.
• exRNA stability ensured via extracellular vesicles (EVs) and protein binding, preventing enzymatic degradation.
• Has dual role: beneficial (immune signalling) and harmful (cancer metastasis via gene signalling).

Static Background:

RNA Basics:

• RNA (Ribonucleic Acid) is involved in protein synthesis and gene regulation (mRNA, tRNA, rRNA, microRNA).
• Traditionally considered intracellular molecule, degraded quickly outside due to ribonucleases.

Extracellular Vesicles (EVs):

• Membrane-bound particles secreted by cells carrying RNA, proteins, lipids, enabling intercellular communication.
• Includes exosomes and microvesicles, crucial for transport and protection of exRNA.

Applications / Significance:

• Water Treatment Innovation: exRNA analysis enables precision disinfection, targeting bacterial resistance pathways rather than generic killing.
• Public Health Surveillance: Detects microbial stress and resistance in water systems, improving safety standards.
• Medical Diagnostics (Liquid Biopsy):
  • Cancer: Early detection through RNA signatures before tumour visibility.
  • Cardiology: microRNAs act as early indicators of cardiac stress, more sensitive than traditional biomarkers like troponin.
  • Neurology: Tracks diseases like Alzheimer’s via cerebrospinal fluid RNA markers.
• Therapeutics: Potential to use synthetic exRNA for gene therapy, enabling targeted activation/suppression of genes.
• Precision Medicine: Enables personalised disease monitoring using non-invasive sampling techniques.

Challenges / Risks:

• Stability vs contamination: Persistence in water raises concerns about unintended biological signalling or environmental impacts.
• Technological complexity: Requires advanced sequencing and bioinformatics, limiting scalability in developing regions.
• Regulatory gaps: Lack of guidelines on use of exRNA in diagnostics and therapeutics.
• Ethical concerns: Genetic information profiling via liquid biopsy raises privacy and data protection issues.
• Cancer risk: exRNA-mediated signalling can promote metastasis (seed and soil hypothesis).

Way Forward:

• Integrate exRNA-based monitoring in water quality frameworks for real-time microbial risk assessment.
• Promote R&D in RNA therapeutics and diagnostics under initiatives like Biotechnology Industry Research Assistance Council (BIRAC).
• Develop standardised protocols for exRNA sequencing and interpretation for clinical and environmental use.
• Strengthen bioethics and data governance frameworks for genetic data handling.
• Encourage interdisciplinary research (microbiology + genomics + public health) for scalable applications.